APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mecobalamin API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mecobalamin API Industry Growth and Trends Forecast to 2032

23 December 2025105 pages

Choose your research edition.

Industry ResearchMecobalamin API Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Mecobalamin API Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Mecobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mecobalamin API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Mecobalamin API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Mecobalamin API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mecobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mecobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mecobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mecobalamin API include Yufeng Industry Group, Yabao Pharmaceutical, Eisai, E-CSPC, Novartis, Ningxia Kingvit Pharmaceutical, Merck, HTBA and EUROAPI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mecobalamin API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mecobalamin API market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mecobalamin API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mecobalamin API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mecobalamin API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mecobalamin API Market by Company

Yufeng Industry Group

Yabao Pharmaceutical

Eisai

E-CSPC

Novartis

Ningxia Kingvit Pharmaceutical

Merck

HTBA

EUROAPI

Atom Pharma

Mecobalamin API Segment by Type

Purity≥99%

Purity<99%

Mecobalamin API Segment by Application

Injectable Formulation

Sprays

Oral Formulation

Mecobalamin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mecobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mecobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mecobalamin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mecobalamin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mecobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity≥99% Table 2. Major Company of Purity<99% Table 3. Global Mecobalamin API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mecobalamin API Sales by Type (2021-2026) & (kg) Table 5. Global Mecobalamin API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mecobalamin API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mecobalamin API Sales Market Share in Value by Type (2021-2026) Table 8. Global Mecobalamin API Price by Type (2021-2026) & (USD/g) Table 9. Global Mecobalamin API Sales by Type (2027-2032) & (kg) Table 10. Global Mecobalamin API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mecobalamin API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mecobalamin API Sales Market Share in Value by Type (2027-2032) Table 13. Global Mecobalamin API Price by Type (2027-2032) & (USD/g) Table 14. North America Mecobalamin API Sales by Type (2021-2026) & (kg) Table 15. North America Mecobalamin API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mecobalamin API Sales by Type (2021-2026) & (kg) Table 17. Europe Mecobalamin API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mecobalamin API Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Mecobalamin API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mecobalamin API Sales by Type (2021-2026) & (kg) Table 21. Latin America Mecobalamin API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mecobalamin API Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Mecobalamin API Sales by Type (2021-2026) & (US$ Million) Table 24. Mecobalamin API Industry Trends Table 25. Mecobalamin API Industry Drivers Table 26. Mecobalamin API Industry Opportunities and Challenges Table 27. Mecobalamin API Industry Restraints Table 28. Global Mecobalamin API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mecobalamin API Revenue Market Share by Company (2021-2026) Table 30. Global Mecobalamin API Sales by Company (2021-2026) & (kg) Table 31. Global Mecobalamin API Sales Share by Company (2021-2026) Table 32. Global Mecobalamin API Market Price by Company (2021-2026) & (USD/g) Table 33. Global Mecobalamin API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mecobalamin API Major Company Production Sites and Headquarters Table 35. Global Mecobalamin API Company, Product Type & Application Table 36. Global Mecobalamin API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mecobalamin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mecobalamin API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mecobalamin API Sales by Region (2021-2026) & (kg) Table 41. Global Mecobalamin API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mecobalamin API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mecobalamin API Sales Market Share in Value by Region (2021-2026) Table 44. Global Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Mecobalamin API Sales by Region (2027-2032) & (kg) Table 46. Global Mecobalamin API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mecobalamin API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mecobalamin API Sales Market Share in Value by Region (2027-2032) Table 49. Global Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Mecobalamin API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mecobalamin API Sales by Application (2021-2026) & (kg) Table 52. Global Mecobalamin API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mecobalamin API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mecobalamin API Sales Market Share in Value by Application (2021-2026) Table 55. Global Mecobalamin API Price by Application (2021-2026) & (USD/g) Table 56. Global Mecobalamin API Sales by Application (2027-2032) & (kg) Table 57. Global Mecobalamin API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mecobalamin API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mecobalamin API Sales Market Share in Value by Application (2027-2032) Table 60. Global Mecobalamin API Price by Application (2027-2032) & (USD/g) Table 61. North America Mecobalamin API Sales by Application (2021-2026) & (kg) Table 62. North America Mecobalamin API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mecobalamin API Sales by Application (2021-2026) & (kg) Table 64. Europe Mecobalamin API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mecobalamin API Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Mecobalamin API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mecobalamin API Sales by Application (2021-2026) & (kg) Table 68. Latin America Mecobalamin API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mecobalamin API Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Mecobalamin API Sales by Application (2021-2026) & (US$ Million) Table 71. Yufeng Industry Group Company Information Table 72. Yufeng Industry Group Business Overview Table 73. Yufeng Industry Group Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. Yufeng Industry Group Mecobalamin API Product Portfolio Table 75. Yufeng Industry Group Recent Development Table 76. Yabao Pharmaceutical Company Information Table 77. Yabao Pharmaceutical Business Overview Table 78. Yabao Pharmaceutical Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. Yabao Pharmaceutical Mecobalamin API Product Portfolio Table 80. Yabao Pharmaceutical Recent Development Table 81. Eisai Company Information Table 82. Eisai Business Overview Table 83. Eisai Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. Eisai Mecobalamin API Product Portfolio Table 85. Eisai Recent Development Table 86. E-CSPC Company Information Table 87. E-CSPC Business Overview Table 88. E-CSPC Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. E-CSPC Mecobalamin API Product Portfolio Table 90. E-CSPC Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 94. Novartis Mecobalamin API Product Portfolio Table 95. Novartis Recent Development Table 96. Ningxia Kingvit Pharmaceutical Company Information Table 97. Ningxia Kingvit Pharmaceutical Business Overview Table 98. Ningxia Kingvit Pharmaceutical Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 99. Ningxia Kingvit Pharmaceutical Mecobalamin API Product Portfolio Table 100. Ningxia Kingvit Pharmaceutical Recent Development Table 101. Merck Company Information Table 102. Merck Business Overview Table 103. Merck Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 104. Merck Mecobalamin API Product Portfolio Table 105. Merck Recent Development Table 106. HTBA Company Information Table 107. HTBA Business Overview Table 108. HTBA Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 109. HTBA Mecobalamin API Product Portfolio Table 110. HTBA Recent Development Table 111. EUROAPI Company Information Table 112. EUROAPI Business Overview Table 113. EUROAPI Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 114. EUROAPI Mecobalamin API Product Portfolio Table 115. EUROAPI Recent Development Table 116. Atom Pharma Company Information Table 117. Atom Pharma Business Overview Table 118. Atom Pharma Mecobalamin API Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 119. Atom Pharma Mecobalamin API Product Portfolio Table 120. Atom Pharma Recent Development Table 121. North America Mecobalamin API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 122. North America Mecobalamin API Sales by Country (2021-2026) & (kg) Table 123. North America Mecobalamin API Sales Market Share by Country (2021-2026) Table 124. North America Mecobalamin API Sales Forecast by Country (2027-2032) & (kg) Table 125. North America Mecobalamin API Sales Market Share Forecast by Country (2027-2032) Table 126. North America Mecobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Mecobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Mecobalamin API Market Share by Country (2021-2026) Table 129. North America Mecobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Mecobalamin API Market Share Forecast by Country (2027-2032) Table 131. Europe Mecobalamin API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 132. Europe Mecobalamin API Sales by Country (2021-2026) & (kg) Table 133. Europe Mecobalamin API Sales Market Share by Country (2021-2026) Table 134. Europe Mecobalamin API Sales Forecast by Country (2027-2032) & (kg) Table 135. Europe Mecobalamin API Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Mecobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Mecobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Mecobalamin API Market Share by Country (2021-2026) Table 139. Europe Mecobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Mecobalamin API Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Mecobalamin API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Mecobalamin API Sales by Country (2021-2026) & (kg) Table 143. Asia-Pacific Mecobalamin API Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Mecobalamin API Sales Forecast by Country (2027-2032) & (kg) Table 145. Asia-Pacific Mecobalamin API Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Mecobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Mecobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Mecobalamin API Market Share by Country (2021-2026) Table 149. Asia-Pacific Mecobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Mecobalamin API Market Share Forecast by Country (2027-2032) Table 151. Latin America Mecobalamin API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 152. Latin America Mecobalamin API Sales by Country (2021-2026) & (kg) Table 153. Latin America Mecobalamin API Sales Market Share by Country (2021-2026) Table 154. Latin America Mecobalamin API Sales Forecast by Country (2027-2032) & (kg) Table 155. Latin America Mecobalamin API Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Mecobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Mecobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Mecobalamin API Market Share by Country (2021-2026) Table 159. Latin America Mecobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Mecobalamin API Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Mecobalamin API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Mecobalamin API Sales by Country (2021-2026) & (kg) Table 163. Middle East and Africa Mecobalamin API Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Mecobalamin API Sales Forecast by Country (2027-2032) & (kg) Table 165. Middle East and Africa Mecobalamin API Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Mecobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Mecobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Mecobalamin API Market Share by Country (2021-2026) Table 169. Middle East and Africa Mecobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Mecobalamin API Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Mecobalamin API Distributors List Table 174. Mecobalamin API Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Mecobalamin API Image Figure 2. Global Mecobalamin API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mecobalamin API Market Size (2021-2032) & (US$ Million) Figure 4. Global Mecobalamin API Sales (2021-2032) & (kg) Figure 5. Purity≥99% Image Figure 6. Global Purity≥99% Sales YoY Growth (2021-2032) & (kg) Figure 7. Purity<99% Image Figure 8. Global Purity<99% Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Mecobalamin API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mecobalamin API Market Share by Type 2025 VS 2032 Figure 11. North America Mecobalamin API Sales Market Share in Volume by Type in 2025 Figure 12. North America Mecobalamin API Sales Market Share in Value by Type in 2025 Figure 13. Europe Mecobalamin API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mecobalamin API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mecobalamin API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mecobalamin API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mecobalamin API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mecobalamin API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mecobalamin API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mecobalamin API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mecobalamin API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Injectable Formulation Image Figure 24. Global Injectable Formulation Sales YoY Growth (2021-2032) & (kg) Figure 25. Sprays Image Figure 26. Global Sprays Sales YoY Growth (2021-2032) & (kg) Figure 27. Oral Formulation Image Figure 28. Global Oral Formulation Sales YoY Growth (2021-2032) & (kg) Figure 29. Global Mecobalamin API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Mecobalamin API Market Share by Application 2025 VS 2032 Figure 31. North America Mecobalamin API Sales Market Share in Volume by Application in 2025 Figure 32. North America Mecobalamin API Sales Market Share in Value by Application in 2025 Figure 33. Europe Mecobalamin API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Mecobalamin API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Mecobalamin API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Mecobalamin API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Mecobalamin API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Mecobalamin API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Mecobalamin API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Mecobalamin API Sales Market Share in Value by Application in 2025 Figure 41. North America Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 42. North America Mecobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Mecobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Mecobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. Europe Mecobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mecobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Mecobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Asia-Pacific Mecobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mecobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Mecobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Latin America Mecobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mecobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Mecobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Middle East and Africa Mecobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mecobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Mecobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Mecobalamin API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Mecobalamin API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥99%
  • Purity<99%
Applications
  • Injectable Formulation
  • Sprays
  • Oral Formulation
Companies covered
  • Yufeng Industry Group
  • Yabao Pharmaceutical
  • Eisai
  • E-CSPC
  • Novartis
  • Ningxia Kingvit Pharmaceutical
  • Merck
  • HTBA
  • EUROAPI
  • Atom Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mecobalamin API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mecobalamin API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mecobalamin API Market by Type
  6. 1.3.1 Purity≥99%
  7. 1.3.2 Purity<99%
  8. 1.4 Global Mecobalamin API Market Size by Type
  9. 1.4.1 Global Mecobalamin API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mecobalamin API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mecobalamin API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mecobalamin API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mecobalamin API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mecobalamin API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mecobalamin API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mecobalamin API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mecobalamin API Industry Trends
  2. 2.2 Mecobalamin API Industry Drivers
  3. 2.3 Mecobalamin API Industry Opportunities and Challenges
  4. 2.4 Mecobalamin API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mecobalamin API Revenue (2021-2026)
  2. 3.2 Global Top Players by Mecobalamin API Sales (2021-2026)
  3. 3.3 Global Top Players by Mecobalamin API Price (2021-2026)
  4. 3.4 Global Mecobalamin API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mecobalamin API Major Company Production Sites & Headquarters
  6. 3.6 Global Mecobalamin API Company, Product Type & Application
  7. 3.7 Global Mecobalamin API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mecobalamin API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mecobalamin API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mecobalamin API Tier 1, Tier 2, and Tier 3
4 Mecobalamin API Regional Status and Outlook
  1. 4.1 Global Mecobalamin API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mecobalamin API Historic Market Size by Region
  3. 4.2.1 Global Mecobalamin API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mecobalamin API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mecobalamin API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mecobalamin API Forecasted Market Size by Region
  7. 4.3.1 Global Mecobalamin API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mecobalamin API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mecobalamin API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mecobalamin API by Application
  1. 5.1 Mecobalamin API Market by Application
  2. 5.1.1 Injectable Formulation
  3. 5.1.2 Sprays
  4. 5.1.3 Oral Formulation
  5. 5.2 Global Mecobalamin API Market Size by Application
  6. 5.2.1 Global Mecobalamin API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mecobalamin API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mecobalamin API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mecobalamin API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mecobalamin API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mecobalamin API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mecobalamin API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mecobalamin API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yufeng Industry Group
  2. 6.1.1 Yufeng Industry Group Company Information
  3. 6.1.2 Yufeng Industry Group Business Overview
  4. 6.1.3 Yufeng Industry Group Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yufeng Industry Group Mecobalamin API Product Portfolio
  6. 6.1.5 Yufeng Industry Group Recent Developments
  7. 6.2 Yabao Pharmaceutical
  8. 6.2.1 Yabao Pharmaceutical Company Information
  9. 6.2.2 Yabao Pharmaceutical Business Overview
  10. 6.2.3 Yabao Pharmaceutical Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yabao Pharmaceutical Mecobalamin API Product Portfolio
  12. 6.2.5 Yabao Pharmaceutical Recent Developments
  13. 6.3 Eisai
  14. 6.3.1 Eisai Company Information
  15. 6.3.2 Eisai Business Overview
  16. 6.3.3 Eisai Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eisai Mecobalamin API Product Portfolio
  18. 6.3.5 Eisai Recent Developments
  19. 6.4 E-CSPC
  20. 6.4.1 E-CSPC Company Information
  21. 6.4.2 E-CSPC Business Overview
  22. 6.4.3 E-CSPC Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 E-CSPC Mecobalamin API Product Portfolio
  24. 6.4.5 E-CSPC Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Mecobalamin API Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Ningxia Kingvit Pharmaceutical
  32. 6.6.1 Ningxia Kingvit Pharmaceutical Company Information
  33. 6.6.2 Ningxia Kingvit Pharmaceutical Business Overview
  34. 6.6.3 Ningxia Kingvit Pharmaceutical Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ningxia Kingvit Pharmaceutical Mecobalamin API Product Portfolio
  36. 6.6.5 Ningxia Kingvit Pharmaceutical Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck Mecobalamin API Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 HTBA
  44. 6.8.1 HTBA Company Information
  45. 6.8.2 HTBA Business Overview
  46. 6.8.3 HTBA Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 HTBA Mecobalamin API Product Portfolio
  48. 6.8.5 HTBA Recent Developments
  49. 6.9 EUROAPI
  50. 6.9.1 EUROAPI Company Information
  51. 6.9.2 EUROAPI Business Overview
  52. 6.9.3 EUROAPI Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 EUROAPI Mecobalamin API Product Portfolio
  54. 6.9.5 EUROAPI Recent Developments
  55. 6.10 Atom Pharma
  56. 6.10.1 Atom Pharma Company Information
  57. 6.10.2 Atom Pharma Business Overview
  58. 6.10.3 Atom Pharma Mecobalamin API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Atom Pharma Mecobalamin API Product Portfolio
  60. 6.10.5 Atom Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Mecobalamin API Sales by Country
  2. 7.1.1 North America Mecobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mecobalamin API Sales by Country (2021-2026)
  4. 7.1.3 North America Mecobalamin API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mecobalamin API Market Size by Country
  6. 7.2.1 North America Mecobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mecobalamin API Market Size by Country (2021-2026)
  8. 7.2.3 North America Mecobalamin API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mecobalamin API Sales by Country
  2. 8.1.1 Europe Mecobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mecobalamin API Sales by Country (2021-2026)
  4. 8.1.3 Europe Mecobalamin API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mecobalamin API Market Size by Country
  6. 8.2.1 Europe Mecobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mecobalamin API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mecobalamin API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mecobalamin API Sales by Country
  2. 9.1.1 Asia-Pacific Mecobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mecobalamin API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mecobalamin API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mecobalamin API Market Size by Country
  6. 9.2.1 Asia-Pacific Mecobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mecobalamin API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mecobalamin API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mecobalamin API Sales by Country
  2. 10.1.1 South America Mecobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mecobalamin API Sales by Country (2021-2026)
  4. 10.1.3 South America Mecobalamin API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mecobalamin API Market Size by Country
  6. 10.2.1 South America Mecobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mecobalamin API Market Size by Country (2021-2026)
  8. 10.2.3 South America Mecobalamin API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mecobalamin API Sales by Country
  2. 11.1.1 Middle East and Africa Mecobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mecobalamin API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mecobalamin API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mecobalamin API Market Size by Country
  6. 11.2.1 Middle East and Africa Mecobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mecobalamin API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mecobalamin API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mecobalamin API Value Chain Analysis
  2. 12.1.1 Mecobalamin API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mecobalamin API Production Mode & Process
  7. 12.2 Mecobalamin API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mecobalamin API Distributors
  10. 12.2.3 Mecobalamin API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst